Testosterone Therapy is highly beneficial for patients suffering from Andropause (Age-Related Low-T).
Unfortunately, some individuals can't take Testosterone for medical reasons.
Men with prostate cancer, for example, have long been advised not to take Bio-Identical Testosterone because the treatment could feed and exacerbate the spread of cancerous tissue.
It's long been believed that Testosterone could induce the rapid spread of Prostate Cancer, but this may not always be the case.
New studies are engaging this long-held belief. A recent study reports that some men with metastatic prostate cancer or biochemical recurrence may still use Testosterone Therapy.
This is the first study of its kind, which reports that Low-T Treatment may be an option for a subset of these patients.
Dr. Abraham Morgentaler was the lead researcher for this study conducted on behalf of Harvard Medical School's Beth Israel Deaconess Medical Center. The study was released in the medical journal Androgens: Clinical Research and Therapeutics.
This journal is highly respected and showcases research that involves the use of Testosterone Therapy and other Androgenic medical treatments.
